Oric Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Oric Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Oric Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oric Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $467k | 51k | 9.20 |
| 2023-09-30 | $291k | 48k | 6.05 |
| 2023-06-30 | $436k | 56k | 7.76 |
| 2023-03-31 | $538k | 94k | 5.70 |
| 2022-06-30 | $280k | 62k | 4.48 |
| 2022-03-31 | $322k | 60k | 5.33 |
| 2021-12-31 | $644k | 44k | 14.67 |
| 2021-09-30 | $846k | 40k | 20.92 |
| 2021-03-31 | $645k | 26k | 24.51 |
| 2020-12-31 | $603k | 18k | 33.83 |
| 2020-09-30 | $339k | 14k | 25.03 |
| 2020-06-30 | $346k | 10k | 33.71 |